Understanding What Are the Different Doses of Wegovy for Your Weight Loss Journey

Last reviewed: July 2, 2026

Last updated: July 2, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, the active ingredient in Wegovy, works by activating glucagon-like peptide-1 receptors in your brain to reduce hunger and regulate blood sugar. Unlike many weight loss medications, semaglutide requires a step-wise dosing approach—starting low and increasing gradually over 16 to 20 weeks. PlexusDx delivers compounded semaglutide injections from licensed 503A pharmacies across all 50 states, with one flat monthly price regardless of which dose level your doctor prescribes.

How Semaglutide Doses Progress Over Time

Semaglutide treatment begins at 0.25 milligrams injected once weekly, a dose low enough to let your body adapt to the medication's effects. Each week for the first four weeks, you remain at this starter level while your healthcare provider monitors your response and any side effects you experience. After the initial month, most patients move to 0.5 mg weekly, which is when appetite suppression typically becomes noticeable.

The dose then increases by 0.25 mg increments every four weeks, following this general pattern: 0.5 mg, 0.75 mg, 1.0 mg, 1.5 mg, and finally 2.0 mg weekly. Some patients reach their target dose in 16 weeks, while others may need the full 20-week titration schedule depending on how their body tolerates each increment. Your PlexusDx doctor will adjust your progression based on your individual tolerance and weight loss goals, rather than rushing you through the escalation.

Understanding Maintenance Dose vs. Starting Dose

The starting dose of 0.25 mg is intentionally low because it allows your gastrointestinal system to adjust without overwhelming side effects like nausea or constipation. This low beginning dose does not typically produce significant weight loss on its own; it is a tolerance-building phase. Think of it as your body's adjustment period before the medication begins working at full therapeutic strength.

Maintenance doses—usually between 1.0 mg and 2.0 mg weekly—are where sustained weight loss occurs in clinical trials. At these higher doses, semaglutide achieves its greatest appetite-suppressing effects and helps your brain recognize fullness signals more quickly. Most patients see meaningful weight reductions once they stabilize at 1.5 mg or 2.0 mg weekly, often losing 15 to 20 percent of their starting body weight over 68 weeks of consistent treatment.

Why Gradual Dose Increases Matter for Safety

Jumping directly to a high semaglutide dose would overwhelm your digestive system and likely cause severe nausea, vomiting, or loss of appetite so intense that you cannot eat enough to maintain energy levels. The four-week intervals between dose increases give your body time to produce fewer side effects at each new level, a process called titration tolerance. Research shows that patients who follow the standard titration schedule report fewer dropouts due to intolerable side effects compared to those given higher doses too quickly.

Your liver and kidneys also benefit from gradual dosing because they adjust their metabolic processing of the medication without sudden stress. PlexusDx's compounded semaglutide follows the same evidence-based titration schedule used in clinical trials, ensuring you experience the safest possible introduction to treatment. Your dose may need to go up, but your price won't—PlexusDx keeps your monthly cost flat at $189 or higher tier pricing regardless of whether you are at 0.25 mg or 2.0 mg.

Personalizing Your Dose With Genetic Insights

Not every patient responds identically to the same semaglutide dose because genetic differences affect how your body's GLP-1 receptors function and how your metabolism processes the medication. The GLP1R rs6923761 variant, for example, influences the sensitivity of your appetite-control receptors, meaning some people achieve results at 1.0 mg while others need 2.0 mg for the same effect. PlexusDx's Precision Peptide Genetic Test analyzes your peptide-pathway genes across 14 biological pathways and 49 peptides to reveal whether your genetic profile suggests sensitivity to GLP-1 therapy or if a dual-compound approach might work better.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What is the typical starting dose of semaglutide for weight loss?

The standard starting dose is 0.25 mg injected once weekly for the first four weeks. This low dose allows your body to adjust to the medication before escalating. PlexusDx delivers this dose via compounded semaglutide injections from licensed 503A pharmacies, with consistent monthly pricing regardless of dose level.

How long does it take to reach the full therapeutic dose?

Most patients reach their maintenance dose between 16 and 20 weeks, increasing by 0.25 mg every four weeks. Some individuals may need longer if side effects occur, while others progress quickly. Your PlexusDx doctor customizes your timeline based on your tolerance and weight loss response.

Does PlexusDx charge more for higher semaglutide doses?

No. PlexusDx's pricing model keeps your monthly cost flat regardless of your dose level—at $189/mo month-to-month, or from $149/mo on the 6-month plan for compounded semaglutide injection across all commitment tiers. Your dose may need to go up, but your price won't.

What side effects occur at different dose levels?

Lower starting doses (0.25–0.5 mg) typically cause mild nausea or loss of appetite in 10–15 percent of users. Higher maintenance doses (1.5–2.0 mg) may increase gastrointestinal side effects like constipation or vomiting, though these usually subside within days. Gradual titration significantly reduces the severity and duration of side effects.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Wegovy For Weight Loss 2
• Wegovy Weight Loss Pills
• Wegovy Vs Zepbound Weight Loss
• Wegovy Weight Loss

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.